Statistics for Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Total visits
views | |
---|---|
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial | 3 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 3 |
File Visits
views | |
---|---|
BarrosoSousa2022Cardiac-CCBY.pdf | 1 |
Top country views
views | |
---|---|
United States | 2 |
China | 1 |
Top city views
views | |
---|---|
Indianapolis | 2 |
Hangzhou | 1 |